ROBERT THOMAS: Open Payments
NPI 1053414110 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 80 payments from 13 companies in 2025. Trend: 2023 $1,056 · 2024 $1,107 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $378 |
| Organon LLC | 23 | $158 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| PFIZER INC. | 5 | $100 |
| Regeneron Healthcare Solutions, Inc. | 5 | $92 |
| Galderma Laboratories, L.P. | 4 | $65 |
| Arcutis Biotherapeutics, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $29 |
| UCB, Inc. | 2 | $29 |
| Amgen Inc. | 1 | $19 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, RINVOQ, CIBINQO, VTAMA, HADLIMA, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
